1. Market Research
  2. > Business Services
  3. > Research and Development Market Trends
  4. > Kasiak Research Pvt. Ltd. - Product Pipeline Review - 2014

Kasiak Research Pvt. Ltd. - Product Pipeline Review - 2014

  • November 2014
  • -
  • Global Markets Direct
  • -
  • 26 pages

Kasiak Research Pvt. Ltd. - Product Pipeline Review - 2014

Summary

Global Markets Direct’s, ‘Kasiak Research Pvt. Ltd. - Product Pipeline Review - 2014’, provides an overview of the Kasiak Research Pvt. Ltd.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Kasiak Research Pvt. Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Kasiak Research Pvt. Ltd. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Kasiak Research Pvt. Ltd.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Kasiak Research Pvt. Ltd.’s pipeline products

Reasons to buy

- Evaluate Kasiak Research Pvt. Ltd.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Kasiak Research Pvt. Ltd. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Kasiak Research Pvt. Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Kasiak Research Pvt. Ltd. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Kasiak Research Pvt. Ltd.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Kasiak Research Pvt. Ltd. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

Table Of Contents

Kasiak Research Pvt. Ltd. - Product Pipeline Review - 2014
Table of Contents

Kasiak Research Pvt. Ltd. Snapshot 5
Kasiak Research Pvt. Ltd. Overview 5
Key Information 5
Key Facts 5
Kasiak Research Pvt. Ltd. - Research and Development Overview 6
Key Therapeutic Areas 6
Kasiak Research Pvt. Ltd. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Kasiak Research Pvt. Ltd. - Pipeline Products Glance 10
Kasiak Research Pvt. Ltd. - Clinical Stage Pipeline Products 10
Phase II Products/Combination Treatment Modalities 10
Phase I Products/Combination Treatment Modalities 11
Kasiak Research Pvt. Ltd. - Early Stage Pipeline Products 12
Preclinical Products/Combination Treatment Modalities 12
Kasiak Research Pvt. Ltd. - Unknown Stage Pipeline Products 13
Unknown Products/Combination Treatment Modalities 13
Kasiak Research Pvt. Ltd. - Drug Profiles 14
Refaglo 14
Product Description 14
Mechanism of Action 14
RandD Progress 14
Refagro 15
Product Description 15
Mechanism of Action 15
RandD Progress 15
Refaheal 16
Product Description 16
Mechanism of Action 16
RandD Progress 16
Refacell-CLI 17
Product Description 17
Mechanism of Action 17
RandD Progress 17
Refacell-IPF 18
Product Description 18
Mechanism of Action 18
RandD Progress 18
Refacell-DCM 19
Product Description 19
Mechanism of Action 19
RandD Progress 19
Refacell-T1D 20
Product Description 20
Mechanism of Action 20
RandD Progress 20
Kasiak Research Pvt. Ltd. - Pipeline Analysis 21
Kasiak Research Pvt. Ltd. - Pipeline Products by Route of Administration 21
Kasiak Research Pvt. Ltd. - Pipeline Products by Molecule Type 22
Kasiak Research Pvt. Ltd. - Recent Pipeline Updates 23
Kasiak Research Pvt. Ltd. - Locations And Subsidiaries 24
Head Office 24
Other Locations and Subsidiaries 24
Appendix 25
Methodology 25
Coverage 25
Secondary Research 25
Primary Research 25
Expert Panel Validation 25
Contact Us 26
Disclaimer 26

List of Tables

Kasiak Research Pvt. Ltd., Key Information 5
Kasiak Research Pvt. Ltd., Key Facts 5
Kasiak Research Pvt. Ltd. - Pipeline by Indication, 2014 7
Kasiak Research Pvt. Ltd. - Pipeline by Stage of Development, 2014 8
Kasiak Research Pvt. Ltd. - Monotherapy Products in Pipeline, 2014 9
Kasiak Research Pvt. Ltd. - Phase II, 2014 10
Kasiak Research Pvt. Ltd. - Phase I, 2014 11
Kasiak Research Pvt. Ltd. - Preclinical, 2014 12
Kasiak Research Pvt. Ltd. - Unknown, 2014 13
Kasiak Research Pvt. Ltd. - Pipeline by Route of Administration, 2014 21
Kasiak Research Pvt. Ltd. - Pipeline by Molecule Type, 2014 22
Kasiak Research Pvt. Ltd. - Recent Pipeline Updates, 2014 23
Kasiak Research Pvt. Ltd., Other Locations 24

List of Figures

Kasiak Research Pvt. Ltd. - Pipeline by Top 10 Indication, 2014 7
Kasiak Research Pvt. Ltd. - Pipeline by Stage of Development, 2014 8
Kasiak Research Pvt. Ltd. - Monotherapy Products in Pipeline, 2014 9
Kasiak Research Pvt. Ltd. - Pipeline by Top 10 Route of Administration, 2014 21
Kasiak Research Pvt. Ltd. - Pipeline by Top 10 Molecule Type, 2014 22

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Pulmonary Fibrosis - Pipeline Review, H2 2016

Pulmonary Fibrosis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Pulmonary Fibrosis - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Pulmonary Fibrosis - Pipeline Review, H2 2016’, provides an overview of the Pulmonary Fibrosis pipeline landscape. ...

Cognitive Impairment - Pipeline Review, H2 2016

Cognitive Impairment - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Cognitive Impairment - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Cognitive Impairment - Pipeline Review, H2 2016’, provides an overview of the Cognitive Impairment pipeline landscape. ...

Suven Life Sciences Ltd. - Product Pipeline Review - 2016

Suven Life Sciences Ltd. - Product Pipeline Review - 2016

  • $ 1500
  • Company report
  • September 2016
  • by Global Markets Direct

Suven Life Sciences Ltd. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Suven Life Sciences Ltd. - Product Pipeline Review - 2016’, provides an overview of the Suven Life Sciences ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.